HENDERSON MOLLY (CFO and CBO) sold 6.6% of their position (6.58K shares) of PHATHOM PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $43.4K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/23/2025ACC: 0000950170-25-008357
Officer· CFO and CBO
Since Apr 2022
-6.58K
Net shares
Net seller
$43.4K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
6.58K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−6.58K
Price / share
$6.59
Trade value
$43.37K
% of position
6.6%
1/21/2025
100.13K→93.55K
Total
Net shares
−6.58K
Net value
-$43.37K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/21/2025 | S · Sale | −6.58K | $6.59 | $43.37K | 6.6% | 100.13K | 93.55K |
| Total | −6.58K | -$43.37K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned1.91K
Total
1.91K indirect1.91K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.91K | Indirect |
| Total | 1.91K | 1.91K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported